Sera Prognostics Stock Probability Of Bankruptcy

SERA Stock  USD 8.60  0.18  2.05%   
Sera Prognostics' chance of distress is under 24% at this time. It has slight odds of undergoing some form of financial hardship in the near future. Chance of distress shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Sera balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Sera Prognostics Piotroski F Score and Sera Prognostics Altman Z Score analysis.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.
  

Sera Prognostics Company chance of distress Analysis

Sera Prognostics' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Sera Prognostics Probability Of Bankruptcy

    
  Less than 24%  
Most of Sera Prognostics' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sera Prognostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Sera Prognostics probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Sera Prognostics odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Sera Prognostics financial health.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
0.003
Quarterly Revenue Growth
(0.31)
Return On Assets
(0.27)
Return On Equity
(0.50)
The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sera Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Sera Prognostics is extremely important. It helps to project a fair market value of Sera Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Sera Prognostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sera Prognostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sera Prognostics' interrelated accounts and indicators.
0.990.970.6-0.63-0.780.89-0.790.71-0.970.990.770.990.97-0.820.49-0.390.47-0.39
0.990.990.7-0.52-0.850.89-0.820.8-1.01.00.780.980.93-0.830.5-0.510.57-0.51
0.970.990.78-0.42-0.910.86-0.830.87-1.00.990.790.940.89-0.830.5-0.610.66-0.61
0.60.70.780.23-0.960.55-0.710.99-0.760.70.660.540.42-0.570.37-0.910.95-0.91
-0.63-0.52-0.420.230.01-0.510.250.090.45-0.53-0.26-0.68-0.780.47-0.24-0.350.34-0.35
-0.78-0.85-0.91-0.960.01-0.720.84-0.990.89-0.85-0.79-0.73-0.620.65-0.370.81-0.850.81
0.890.890.860.55-0.51-0.72-0.590.66-0.890.890.560.90.88-0.870.61-0.330.38-0.33
-0.79-0.82-0.83-0.710.250.84-0.59-0.760.82-0.81-0.97-0.76-0.670.380.010.53-0.580.53
0.710.80.870.990.09-0.990.66-0.76-0.850.80.710.660.55-0.670.44-0.870.91-0.87
-0.97-1.0-1.0-0.760.450.89-0.890.82-0.85-1.0-0.79-0.96-0.90.83-0.510.57-0.630.57
0.991.00.990.7-0.53-0.850.89-0.810.8-1.00.780.980.94-0.840.5-0.510.56-0.51
0.770.780.790.66-0.26-0.790.56-0.970.71-0.790.780.730.63-0.350.07-0.40.59-0.4
0.990.980.940.54-0.68-0.730.9-0.760.66-0.960.980.730.99-0.820.46-0.340.39-0.34
0.970.930.890.42-0.78-0.620.88-0.670.55-0.90.940.630.99-0.810.44-0.250.25-0.25
-0.82-0.83-0.83-0.570.470.65-0.870.38-0.670.83-0.84-0.35-0.82-0.81-0.840.45-0.490.45
0.490.50.50.37-0.24-0.370.610.010.44-0.510.50.070.460.44-0.84-0.20.45-0.2
-0.39-0.51-0.61-0.91-0.350.81-0.330.53-0.870.57-0.51-0.4-0.34-0.250.45-0.2-0.841.0
0.470.570.660.950.34-0.850.38-0.580.91-0.630.560.590.390.25-0.490.45-0.84-0.84
-0.39-0.51-0.61-0.91-0.350.81-0.330.53-0.870.57-0.51-0.4-0.34-0.250.45-0.21.0-0.84
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Sera Prognostics has a Probability Of Bankruptcy of 24.0%. This is 44.56% lower than that of the Biotechnology sector and 41.23% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 39.74% higher than that of the company.

Sera Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sera Prognostics' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sera Prognostics could also be used in its relative valuation, which is a method of valuing Sera Prognostics by comparing valuation metrics of similar companies.
Sera Prognostics is currently under evaluation in probability of bankruptcy category among its peers.

Sera Prognostics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sera Prognostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sera Prognostics' managers, analysts, and investors.
Environmental
Governance
Social

Sera Fundamentals

About Sera Prognostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sera Prognostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sera Prognostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sera Prognostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:
Check out Sera Prognostics Piotroski F Score and Sera Prognostics Altman Z Score analysis.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
0.003
Quarterly Revenue Growth
(0.31)
Return On Assets
(0.27)
Return On Equity
(0.50)
The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.